Search

everythinglearnresearchcommunity

for

Search:↓

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

No effective treatment for hair loss after childbirth was found, but it usually gets better on its own and some cosmetic methods might help.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Cyclosporin is effective for treating skin conditions in small animals, but requires careful dosing and monitoring for side effects.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

COVID-19 may harm male fertility and damage the reproductive system.

Phenobarbitone can cause severe and sometimes fatal skin reactions.

The article suggests that the belief in common postpartum hair loss lacks sufficient evidence and may be overestimated.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

L-Cystine and L-Cystine with Kera-Diet® safely improved hair and nail quality in healthy women.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Taking finasteride daily can effectively and safely increase hair density and thickness for women with hair loss.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

Finasteride 5mg/day improves hair loss in normoandrogenic Asian women.

Itraconazole is potentially effective for treating invasive aspergillosis, but more research is needed.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Toxic Shock Syndrome mainly affects menstruating women, can recur, and is linked to staph bacteria, with rapid treatment being crucial.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

PLD is an effective and safer alternative for treating breast cancer.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.